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Abstract
© 2016, Springer Science+Business Media New York.Tescalcin plays an important role in the
proliferation and differentiation of certain cell types. It is involved in the regulation of expression
of Ets family transcription factors through PMA-induced ERK pathway. This pathway is known to
regulate the proliferation and differentiation of mesenchymal stem cells (MSC). Research and
development of cell therapy applications using human adipose-derived stem cells (hADSCs) is
important  for  regenerative medicine,  since the hADSCs are easy to  obtain and have high
proliferative and differentiation potential. It is of particular interest to create stable MSC lines
with continuous and controlled expression of tescalcin to assess the potential role of the protein
in differentiation of stem cells. Recombinant lentiviruses are often used for genetic modification
of cells since it allows long-term expression of transgene due to integration of the provirus into
the genome of host cell, relatively large size of transgenic insert and ease of manipulation.
Here, we report generation of stable hADSC cell lines with ectopic expression of tescalcin using
lentiviral transduction.
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